Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Spinifex Pharmaceuticals
Spinifex Pharmaceuticals
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Spinifex Pharmaceuticals sold to Novartis
Novartis will continue to develop the company’s programmes to address neuropathic pain
Research & Development
Spinifex Pharmaceuticals makes two senior appointments in CMC team
Peter Spargo joins as SVP, CMC with Christine Richardson as Director, CMC and Nonclinical Project Manager
Research & Development
Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer
Ronald Marcus joins the Australian-US biotechnology company
Regulatory
Neuropathic pain – EMA401
Pain that arises as a direct consequence of a lesion or disease affecting the somatosensory system is notoriously difficult to treat
Subscribe now